STAQ Pharma Ketamine Injection Recall: Missing Lot/Exp Date
STAQ Pharma recalls 50mL ketamine IV injection with missing lot or expiration date. Patients should check labels for correct dates to avoid medication errors.
Lower-risk recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Contact the company
What happened, in plain English
STAQ Pharma is recalling a specific ketamine injection product due to missing or incorrect lot and expiration dates on the label. This could lead to medication errors if the wrong batch is used. Read more at govinfonow.com/recall/31741-staq-pharma-ketamine-injection-recall-missing-lot-exp-date.
Source Summary by GovInfoNow · govinfonow.com/recall/31741-staq-pharma-ketamine-injection-recall-missing-lot-exp-date · Updated August 17, 2026 · FDA enforcement record: FDA #D-0024-2026
Cite this page
“STAQ Pharma Ketamine Injection Recall: Missing Lot/Exp Date.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31741-staq-pharma-ketamine-injection-recall-missing-lot-exp-date. Based on FDA recall #D-0024-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0024-2026%22&limit=1).
Why it’s dangerous
The injection comes with a label that may not show the correct lot number or expiration date. This could cause medication errors if healthcare providers use the product without checking the label.
Who’s affected
Healthcare professionals using this ketamine injection for IV procedures in the U.S. are most at risk if they use the product without verifying the label dates.
How to tell if you have this one
Check the label for lot number 25156673A and expiration date February 2026. This product was sold by STAQ Pharma in the U.S. with NDC 73177-0156-02.
- Brand
STAQ Pharma- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Ongoing- Distribution
Nationwide in the U.S.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0023-2026 | Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.; Lot #: 25104595A, Expiry: 27DEC2025. | — |
| D-0024-2026 | Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.; Lot #: 25156673A, Expiry: 02FEB2026. | — |
| D-0025-2026 | FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.; Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025. | — |
What to do — step by step
Check Label Dates
Verify the lot number and expiration date on the product label. If missing or incorrect, do not use the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 13 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0024-2026 (October 9, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0024-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.